Skip to Content

Stage 1 Core Measure 13

Next Measure Previous Measure


Measure at a Glance

Type: calculated percentage

Denominator: office visits

Duration: calculated over the entire EHR reporting period

Objective: Provide clinical summaries for patients for each office visit.
Measure: Clinical summaries provided to patients for more than 50 percent of all office visits within 3 business days.
Exclusion: Any EP who has no office visits during the EHR reporting period.
There are no changes to this objective and measure regardless of when EPs attest to Stage 1 Meaningful Use.

CMS Technical Specification

TennCare Notes

The attestation portal will require the EP to enter the numerator and denominator of the measure as defined in the technical specification.

Please note that this measure requires more than 50% of all unique patients. The attestation numerators and denominators are calculated to the hundredths place in the PIPP Portal, so while a proportion of 50.01% will be evaluated as a successful attestation, 50.00% will not.

Relevant CMS FAQs

  • 10558: defining clinical summary
  • 10166: providing clinical summaries to patients whose visits span multiple days, EPs

Additional Resources
None at this time.

Federal Regulations Governing This Measure

CMS' Final Rule

§ 495.6(d)(13) see objective, measure and exclusion above

Standards and Certification Final Rule

§ 170.304(h) Clinical summaries. Enable a user to provide clinical summaries to patients for each office visit that include, at a minimum, diagnostic test results, problem list, medication list, and medication allergy list. If the clinical summary is provided electronically it must be:

  1. Provided in human readable format; and
  2. Provided on electronic media or through some other electronic means in accordance with:
    1. The standard (and applicable implementation specifications) specified in Sec. 170.205(a)(1) or Sec. 170.205(a)(2); and
    2. For the following data elements the applicable standard must be used:
      1. Problems. The standard specified in Sec. 170.207(a)(1) or, at a minimum, the version of the standard specified in Sec. 170.207(a)(2);
      2. Laboratory test results. At a minimum, the version of the standard specified in Sec. 170.207(c); and
      3. Medications. The standard specified in Sec. 170.207(d).

§ 170.205(a) Patient summary record

  1. Standard. Health Level Seven Clinical Document Architecture (CDA) Release 2, Continuity of Care Document (CCD) (incorporated by reference in Sec. 170.299). Implementation specifications. The Healthcare Information Technology Standards Panel (HITSP) Summary Documents Using HL7 CCD Component HITSP/C32 (incorporated by reference in Sec. 170.299).
  2. Standard. ASTM E2369 Standard Specification for Continuity of Care Record and Adjunct to ASTM E2369 (incorporated by reference in Sec. 170.299).

§ 170.207(a) Problems

  1. Standard. The code set specified at 45 CFR 162.1002(a)(1) for the indicated conditions.
  2. Standard. International Health Terminology Standards Development Organization (IHTSDO) Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT ®) July 2009 version (incorporated by reference in Sec. 170.299).

§ 170.207(c) Laboratory test results. Standard. Logical Observation Identifiers Names and Codes (LOINC ®) version 2.27, when such codes were received within an electronic transaction from a laboratory (incorporated by reference in Sec. 170.299).

§ 170.207(d) Medications. Standard. Any source vocabulary that is included in RxNorm, a standardized nomenclature for clinical drugs produced by the United States National Library of Medicine.